Related Experiment Video
Updated: Jan 24, 2026
05:24
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
Published on: January 10, 2025
785
Advances in pulmonary and pleural malignant disorders
Jack A Kastelik1, Angshu Bhowmik2, John Park3
1Hull University Teaching Hospitals NHS Trust, Cottingham, UK jack.kastelik@hey.nhs.uk.
Clinical Medicine (London, England)
|May 17, 2019
Summary
Diagnosing lung and pleural cancers earlier in the UK is crucial for improving survival rates. New molecular treatments and potential screening programs offer hope for better patient outcomes.
Area of Science:
- Oncology
- Pulmonology
- Medical Diagnostics
Background:
- Lung and pleural malignancies are prevalent in the UK, characterized by poor survival rates often linked to late-stage diagnosis.
- Current diagnostic pathways incorporate advanced imaging like positron emission tomography and endobronchial ultrasound for timely staging.
Purpose of the Study:
- To provide a comprehensive overview of the diagnostic process for pulmonary and pleural malignancies.
- To discuss current and emerging therapeutic options, including molecularly targeted treatments.
- To explore the potential of future lung cancer screening programs in the UK.
Main Methods:
- Review of diagnostic modalities including positron emission tomography and endobronchial ultrasound.
- Analysis of advancements in molecular phenotyping for personalized cancer treatment.
- Examination of the current status and future prospects of lung cancer screening initiatives.
Main Results:
- Late diagnosis significantly contributes to poor survival rates for lung and pleural cancers.
- Molecular phenotyping enables individualized therapeutic strategies.
- Lung cancer screening, though nascent in the UK, shows promise for early detection.
Conclusions:
- Optimizing diagnostic pathways and implementing early screening are vital for improving outcomes in lung and pleural malignancies.
- Personalized medicine through molecular targeting represents a significant advancement in treatment.
- Further development of screening programs is essential for early detection and curative treatment of lung cancer.
Related Concept Videos
01:30Pleural Disorders: Types and Brief Description
641
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
641
01:17Other Pulmonary Disorders
1.6K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.6K
01:25Pleural Effusion I: Introduction
4.1K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.1K
01:28Pleural Effusion II: Symptoms and Management
701
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
701
02:18Intrinsically Disordered Proteins
19.3K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.3K
00:56Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K